Siemens Stock: Record Backlog Meets Restructuring Uncertainty

Siemens posts strong Q1 results with a €120B order backlog, but shares fall 13% as a major Healthineers spin-off plan creates near-term uncertainty for investors.

Siemens AG finds itself navigating one of the most significant corporate transformations in its recent history, a process that is leaving a clear imprint on its share price despite the company posting formidable operational results.

The industrial conglomerate's first quarter for fiscal 2026 presented a picture of robust demand. New orders surged by ten percent to reach €21.4 billion, while revenue advanced by eight percent to €19.1 billion. Adjusted earnings per share saw a notable increase, climbing from €2.22 to €2.80. Perhaps most indicative of future performance is the company's order backlog, which has swelled to a historic peak of €120 billion. A book-to-bill ratio of 1.12 further underscores that new business is being secured faster than it can be fulfilled, laying a solid foundation for the quarters ahead.

Structural Overhaul Weighs on Investor Sentiment

The primary source of current market hesitation appears not to be Siemens' core operations, but rather its planned corporate restructuring. The group intends to transfer a 30% stake in its healthcare subsidiary, Siemens Healthineers, directly to its shareholders. Following this move, the medical technology unit would be held solely as a financial investment. This proposed transaction remains subject to regulatory approvals and the consent of both companies' annual general meetings. Specific details regarding the structure and timeline are anticipated in early Q2 of 2026.

Such profound transformations invariably consume management resources and generate near-term uncertainty, a dynamic reflected in the stock's recent performance. Over the past 30 days, Siemens shares have declined by approximately 13 percent. This drop has pushed the equity well below its 50-day moving average of €247.53, and it has recently breached the 200-day line to the downside.

Digital Ambitions and Shareholder Returns

Concurrently with its portfolio reshaping, Siemens continues to advance its digital strategy with determination. The acquisition of Altair Engineering, finalized in March 2025 for approximately $10 billion, significantly bolstered its capabilities in industrial simulation and AI-driven analytics. Building on this, Siemens and NVIDIA expanded their partnership at the start of 2026, targeting the development of fully AI-controlled manufacturing facilities. The pilot for this initiative will be the Siemens Electronics Factory in Erlangen, set to begin operations in 2026.

Furthermore, the company's share buyback program continues at a substantial pace. Siemens has already deployed €4.4 billion in repurchases, with an additional 18 million shares scheduled to be retired in March—a move that provides arithmetic support to earnings per share.

Leadership Transition Amid a Pivotal Period

Adding to the period of change, Veronika Bienert is slated to assume the role of Chief Financial Officer on April 1, stepping directly into the ongoing transformation. Her first major test will likely be on May 13, when Siemens is scheduled to release its second-quarter results. By that date, the market also expects to have clarity on the concrete terms of the Healthineers transaction. Investors betting on a potential re-rating of the stock will be watching these coming weeks with particular attention.